Stabilized synthetic immunogen delivery system
Abstract
The present invention provides an immunostimulatory complex specifically adapted to act as adjuvant and as a peptide immunogen stabilizer. The immunostimulatory complex comprises a CpG oligonucleotide and a biologically active peptide immunogen. The immunostimulatory complex is particulate and can efficiently present peptide immunogens to the cells of the immune system to produce an immune response. The immunostimulatory complex may be formulated as a suspension for parenteral administration. The immunostimulatory complex may also be formulated in the form of w/o-emulsions or in-situ gelling polymers for the efficient delivery of immunogens to the cells of the immune system of a subject following parenteral administration, to produce an immune response.
Term
Term ended
Projected expiry passed 14 February 2023, 3.6 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
31 members in 14 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 7667402 | United States of America | A | |
| 0304711 | United States of America | W | |
| 35516103 | United States of America | A |
Members31
| Document | Office | Kind | |
|---|---|---|---|
| CA2475102A1 | Canada | A1 | |
| WO03068169A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003213091A1 | Australia | A1 | |
| US2003165478A1 | United States of America | A1 | |
| TW200307557A | Taiwan Province of China | A | |
| US2004009897A1 | United States of America | A1 | |
| MXPA04007935A | Mexico | A | |
| EP1572074A2 | European Patent Office (EPO) | A2 | |
| JP2005530690A | Japan | A | |
| HK1085652A | Hong Kong, China | A | |
| WO03068169A3 | World Intellectual Property Organization (WIPO) | A3 | |
| BR0307724A | Brazil | A | |
| CN101001646A | China | A | |
| EP1572074A4 | European Patent Office (EPO) | A4 | |
| AU2003213091B2 | Australia | B2 | |
| AU2003213091C1 | Australia | C1 | |
| JP2010265291A | Japan | A | |
| US8084015B2 | United States of America | B2 | |
| US8088388B2 | United States of America | B2 | |
| EP1572074B1 | European Patent Office (EPO) | B1 | |
| AT540697T | Austria | T | |
| ATE540697T1This record | Austria | T1 | |
| TWI359025B | Taiwan Province of China | B | |
| DK1572074T3 | Denmark | T3 | |
| ES2383172T3 | Spain | T3 | |
| JP5156170B2 | Japan | B2 | |
| CA2475102C | Canada | C | |
| JP5237997B2 | Japan | B2 | |
| CN101001646B | China | B | |
| BRPI0307724B1 | Brazil | B1 | |
| BRPI0307724B8 | Brazil | B8 |
Numbers
- Application
- 3709134
Titles2
- German
- STABILISIERTES SYNTHETISCHES IMMUNOGEN- ABGABESYSTEM
- English
- STABILIZED SYNTHETIC IMMUNOGEN DELIVERY SYSTEM
Classification
- CPC, 15
- A61K39/0006
- A61K39/39
- A61K2039/55561
- A61K2039/55566
- A61K2039/622
- A61P15/16
- A61P15/18
- A61P25/28
- A61P31/00
- A61P31/12
- A61P31/18
- A61P33/00
- A61P35/00
- A61P37/00
- A61P37/04
- IPC, 21
- C12N15 09
- A61K6 00
- A61K9 06
- A61K9 10
- A61K9 107
- A61K39 00
- A61K39 39
- A61K47 02
- A61K47 10
- A61K47 26
- A61K47 34
- A61K48 00
- A61P15 16
- A61P15 18
- A61P25 28
- A61P31 18
- A61P33 00
- A61P35 00
- A61P37 00
- A61P37 04
- C07K14 155